Authors:
Egbertson, MS
Bednar, B
Askew, BC
Bednar, RA
Brashear, K
Breslin, MJ
Duggan, ME
Fisher, TE
Halczenko, W
Hutchinson, JH
Ihle, N
Prugh, JD
Wai, JS
Gould, RJ
Hartman, GD
Citation: Ms. Egbertson et al., Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors, BIOORG MED, 10(17), 2000, pp. 1943-1948
Authors:
Muller, J
Tvrdik, D
Dvorak, R
Djaborkhel, R
Mandys, V
Bednar, B
Raska, I
Lojda, Z
Citation: J. Muller et al., Expression of beta-catenins and cadherins by follicular dendritic cells inhuman lymph nodes, ACT HISTOCH, 102(4), 2000, pp. 369-380
Authors:
Egbertson, MS
Cook, JJ
Bednar, B
Prugh, JD
Bednar, RA
Gaul, SL
Gould, RJ
Hartman, GD
Homnick, CF
Holahan, MA
Libby, LA
Lynch, JJ
Lynch, RJ
Sitko, GR
Stranieri, MT
Vasallo, LM
Citation: Ms. Egbertson et al., Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation. (vol 42, pg 2409, 1999), J MED CHEM, 42(19), 1999, pp. 4014-4014
Authors:
Egbertson, MS
Cook, JJ
Bednar, B
Prugh, JD
Bednar, RA
Gaul, SL
Gould, RJ
Hartman, GD
Homnick, CF
Holahan, MA
Libby, LA
Lynch, JJ
Lynch, RJ
Sitko, GR
Stranieri, MT
Vassallo, LM
Citation: Ms. Egbertson et al., Non-peptide GPIIb IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation, J MED CHEM, 42(13), 1999, pp. 2409-2421
Authors:
Bennett, JS
Zigmond, S
Vilaire, G
Cunningham, ME
Bednar, B
Citation: Js. Bennett et al., The platelet cytoskeleton regulates the affinity of the integrin alpha(IIb)beta(3) for fibrinogen, J BIOL CHEM, 274(36), 1999, pp. 25301-25307
Authors:
Bednar, B
Cook, JJ
Holahan, MA
Cunningham, ME
Jumes, PA
Bednar, RA
Hartman, GD
Gould, RJ
Citation: B. Bednar et al., Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb IIIa, BLOOD, 94(2), 1999, pp. 587-599